York Region’s medical officer of health says the province has “given us the heads up” that possibly as early as next week second doses will be administered earlier than expected.
The regions top doctor Dr. Karim Kurji said the over 80 age group will be first followed by 70 and older.
“We are currently working through the logistics of this particular move with the objective of being fair and causing the minimal confusion,” Kurji said in a statement.
“At this point in time we are still evaluating our different options.”
Officials from York Region said it was a province-wide directive from the Ontario government on the dosage interval. Officials with the Ontario government said more details on next steps of the vaccination rollout will be provided on Friday.
Read more: Medical experts calling on Ontario to rethink when and how 2nd COVID-19 vaccine doses are given
Due to limited vaccine supply, the Ontario government had implemented a 16-week dosage interval between first and second doses in order to get as many first shots into people’s arm as possible. A move that was seen in the U.K. to provide a wide range of some protection to more of the population.
- Nova Scotia aims to reduce mammogram wait times, enhance women’s health care
- Anthrax outbreak kills more than 50 animals, infects 12 people in Zambia
- Childhood Cancer Canada calls for $15M from feds as demand rises
- ‘E-dirt bikes are not toys’: E.R. doc fears more injuries after 2 kids hit in Edmonton
Get weekly health news
There are a few exceptions, including long-term care and retirement residents who were fully vaccinated and one of the first to receive vaccinations. In May, Ontario also expanded second doses to high-risk health care workers.
In March, many seniors who got a first vaccine dose had their second shots rebooked for four months later. Moving to second doses for the 80-plus group as early as next week could shorten the interval by a month or a couple weeks.
Pfizer’s vaccine was originally developed for a 21-day interval between each shot. Moderna was a 28-day interval and AstraZeneca was developed for between four and twelve weeks.
Comments
Want to discuss? Please read our Commenting Policy first.